Journal of Hepatology
Volume 51, Issue 6 , Pages 1037-1045, December 2009

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication

  • Bo Wang

      Affiliations

    • Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany
    • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Martin Trippler

      Affiliations

    • Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany
  • ,
  • Rongjuan Pei

      Affiliations

    • Institute of Virology, University Hospital of Essen, Essen, Germany
  • ,
  • Mengji Lu

      Affiliations

    • Institute of Virology, University Hospital of Essen, Essen, Germany
  • ,
  • Ruth Broering

      Affiliations

    • Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany
  • ,
  • Guido Gerken

      Affiliations

    • Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany
  • ,
  • Joerg F. Schlaak

      Affiliations

    • Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 201 7232518; fax: +49 201 7235749.

Received 27 January 2009; received in revised form 3 June 2009; accepted 23 June 2009. published online 29 July 2009.

Associate Editor: V. Barnaba

Background/Aims

While hepatic stellate cells (HSC) are known to be key mediators of liver fibrosis, only little is known about their functional role in the innate immune system of the liver.

Methods

To address this question, murine HSC were isolated from livers of C57BL/6J mice and human HSC were isolated from liver samples obtained from resections and liver explants. HSC were stimulated with Toll-like receptor (TLR) 1–9 ligands for 20h. Supernatants were harvested and used in virus protection assays (encephalomyocarditis virus, EMCV) as well as in human and murine hepatitis C virus (HCV) replicon systems. Expression of interferon (IFN), retinoic acid-inducible gene-I (RIG-I), and interferon-stimulated genes (ISGs) was assessed by quantitative reverse transcription polymerase chain reaction.

Results

While all TLRs were detectable in HSC, in murine HSC only TLR 3 and -4 agonists could induce cytokines that had an antiviral effect upon EMCV and HCV replication. IFN-β was the main cytokine mediating the antiviral activity of TLR 3-stimulated HSC whereas other cytokines of undefined nature were involved in TLR 4-mediated antiviral effects. In human HSC, only TLR 3 stimulation led to production of antiviral cytokines. The antiviral effect was related to the up-regulation of ISGs and RIG-I in target cells.

Conclusions

These data demonstrate that murine and human HSC have as yet unrecognized antiviral properties when activated through the TLR-system and TLR 3/HCV in particular. This sheds new light on their role in the innate immune system of the liver and their participation in the control of HCV replication.

Keywords: Toll-like receptors, Hepatic stellate cell, Liver fibrosis, Hepatitis C virus, Interferon

Abbreviations: TLR, Toll-like receptor, HCV, hepatitis C virus, HSC, hepatic stellate cells, KC, Kupffer cells, LSEC, liver sinusoidal endothelial cells, LPS, lipopolysaccharide, Poly I:C, polyinosine-polycytidylic acid, IFN, interferon, IL, interleukin, ISG, interferon-stimulated gene, TNF, tumor necrosis factor, EMCV, encephalomyocarditis virus, Tirap, Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein, RIG-I, retinoic acid-inducible gene-I, OAS, 2,5-oligoadenylate synthetase, MxA, myxovirus-resistance A, IFIT1, interferon-induced protein with tetratricopeptide repeats 1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00473-5

doi:10.1016/j.jhep.2009.06.020

Journal of Hepatology
Volume 51, Issue 6 , Pages 1037-1045, December 2009